Granulocyte-macrophage colony-stimulating factor autoantibodies: a marker of aggressive Crohn's disease.
Granulocyte-macrophage colony-stimulating factor autoantibodies: a marker of aggressive Crohn's disease.
复制标题
DOI:
10.1097/mib.0b013e318281f506
复制
发表时间:
2013-07
影响因子:
4.9
通讯作者:
Denson LA
中科院分区:
文献类型:
--
作者:
Gathungu G;Kim MO;Ferguson JP;Sharma Y;Zhang W;Ng SM;Bonkowski E;Ning K;Simms LA;Croft AR;Stempak JM;Walker N;Huang N;Xiao Y;Silverberg MS;Trapnell B;Cho JH;Radford-Smith GL;Denson LA
Neutralizing auto-antibodies (Ab) against granulocyte-macrophage colony-stimulating factor (GM-CSF Ab) have been associated with stricturing ileal Crohn’s disease (CD) in a largely pediatric patient cohort (total 394, adult CD 57). The aim of this study was to examine this association in two independent predominantly adult inflammatory bowel disease patient cohorts. Serum samples from 745 subjects from the NIDDK IBD Genetics Consortium and 737 patients from Australia were analyzed for GM-CSF Ab and genetic markers. We conducted multiple regression analysis with backwards elimination to assess the contribution of GM-CSF Ab levels, established CD risk alleles and smoking on ileal disease location in the 477 combined CD subjects from both cohorts. We also determined associations of GM-CSF Ab levels with complications requiring surgical intervention in combined CD subjects in both cohorts. Serum samples from CD patients expressed significantly higher concentrations of GM-CSF Ab when compared to Ulcerative Colitis or controls in each cohort. Non-smokers with ileal CD expressed significantly higher GM-CSF Ab concentrations in the Australian cohort (p= 0.002). Elevated GM-CSF Ab, ileal disease location and disease duration greater than 3 years were independently associated with stricturing/penetrating behavior and intestinal resection for CD. The expression of high GM-CSF Ab is a risk marker for aggressive CD behavior and complications including surgery. Modifying factors include environmental exposure to smoking and genetic risk markers.